Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns
British Journal of Haematology · 2026-07 · 209 (1) · 54-62
DOI: 10.1111/bjh.70560 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 26.05.2026. Verfasst von Prateek Bhatia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology-Oncology Unit, Department of Pediatrics, PGIMER, Chandigarh, India. Hauptthemen laut MEDLINE: Mercaptopurine, DNA Mismatch Repair, Mutation, Drug Resistance, Neoplasm. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Acquired thiopurine resistance and mismatch repair (MMR) deficiency are increasingly recognised drivers of relapse in paediatric B‐cell acute lymphoblastic leukaemia (B‐ALL); however, their real‐world genomic prevalence and link to maintenance dosing patterns remain poorly characterised. Paediatric B‐ALL relapse cases (2018–2024) were subjected to whole exome sequencing (WES; 200–250× depth; n = 70) and deep targeted sequencing (700–900×; n = 5). Per‐sample frequencies of resistance gene mutations, single‐base mutational signatures, tumour mutational burden‐high (≥10 mutations/Mb), microsatellite instability‐high (MSI‐H) and thiopurine S‐methyltransferase ( TPMT)/nucleoside diphosphate‐linked moiety X‐type motif 15 (NUDT15) status were determined. Clinical variables included the median weekly 6‐mercaptopurine (6‐MP) dose (mg/m 2 , time‐weighted) and duration of 6‐MP dose interruptions. A total of 18/75 (24%) relapse cases showed SBS87 (thiopurine‐related), SBS6/15 (MMR‐related) or Thio‐deficient mismatch repair (Thio‐dMMR) mutational signature. Thiopurine resistance clones in cytosolic 5'‐nucleotidase II ( NT5C2) (13), phosphoribosyl pyrophosphate synthetase 1 ( PRPS1) (2) or tumor protein p53 ( TP53) (7) were noted in 19/75 (25%) cases; germline or somatic clones in MMR genes were noted in 19/75 (25%). Correlation analysis revealed that both low median weekly 6‐MP dose (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Hematology-Oncology Unit, Department of Pediatrics, PGIMER, Chandigarh, India.
- Pharmacy & Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Hematology, PGIMER, Chandigarh, India.
- Division of Haematology Oncology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Prateek Bhatia, Swetha Palla
Förderung
- Indian Council of Medical Research
Zitieren
APA
Bhatia, P., Sharun, S., Palla, S., Brady, S. W., Kirubanandhan, S., Ansari, S., Singh, M., Sreedharanunni, S., Das, A., & Trehan, A. (2026). Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns. British Journal of Haematology, 209(1), 54-62. https://doi.org/10.1111/bjh.70560
Vancouver
Bhatia P, Sharun S, Palla S, Brady SW, Kirubanandhan S, Ansari S, et al. Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns. British Journal of Haematology. 2026;209(1):54-62. doi:10.1111/bjh.70560
BibTeX
@article{Bhatia2026,
author = {Bhatia, Prateek and Sharun, Sharun and Palla, Swetha and Brady, Samuel W and Kirubanandhan, Sangeetha and Ansari, Sada and Singh, Minu and Sreedharanunni, Sreejesh and Das, Anirban and Trehan, Amita},
title = {Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {1},
pages = {54--62},
doi = {10.1111/bjh.70560}
}
EUVIMED